Replies to post #34776 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

flipper44 Member Level Wednesday, May 13, 2015 11:44:49 AM
Re: iclight post# 34649 Post # of 34776
With dozens of hit articles by AF and his buddies, limited budget and resources (until recently), and a long tail product, I'd say you fail to comprehend the masterful job that NWBO, the CROs and clinics have done moving enrollment along.

For more than approximately 15 months a while back, the first thing that came up when I searched DCVax-L was AF's smug face followed by a caption talking about NWBO blowing up just like IMUC.

These dozens of hit articles certainly took their toll and caused enrollee reticence, but little did AF realize that with a long tail therapeutic effect, he was actually helping DCVax-L results mature. So that might be the ironic silver lining take away from that long drawn out kerfuffle when we look back on all this years from now.

[TZOR]

What do you not understand about a double blinded study?

[iclight]

It's everyone else's fault. The thousands of success stories in Israel should be enough for them to easily complete enrollment with 85 sites on board.